Trial results for a feasibility study on monitoring blood pressure at home for Hypertension were posted on ClinicalTrials.gov on 2026-04-29. The study successfully recruited 24 participants.
Background
Hypertension is a widespread chronic condition that necessitates consistent monitoring and management to prevent serious health complications. Traditional care models often involve in-person clinic visits, but there is growing interest in leveraging remote technologies and telehealth to improve patient engagement and adherence to treatment plans. Assessing the feasibility of home blood pressure monitoring combined with pharmacist and physician contact is crucial for developing more accessible and effective management strategies.
Trial design
This feasibility study, designated as Phase NA, enrolled a total of 24 participants. The study focused on individuals with Hypertension. The overall goal was to determine the feasibility of measuring blood pressure at home and maintaining contact with a team of pharmacists and physicians for blood pressure management. Participants were divided into two groups: 12 patients received remote blood pressure monitoring combined with weekly phone meetings with a pharmacist, while the other 12 patients received usual care.
Key results
The study reported on participant recruitment and retention metrics:
- The Total Number of Recruited Participants across all groups was 24.
- Regarding attendance at the last study visit, 8 participants in the Usual Care group attended, and 8 participants in the Remote Blood Pressure Monitoring + Telehealth group attended.
What this means
The results indicate that recruiting participants for a home blood pressure monitoring and telehealth intervention for hypertension is feasible, with 24 individuals successfully enrolled. The attendance rates for the last study visit were identical between the Usual Care group and the Remote Blood Pressure Monitoring + Telehealth group, both at 8 participants. This suggests that the remote monitoring approach did not negatively impact participant retention for the final visit compared to standard care, supporting its viability for future, larger-scale efficacy trials in hypertension management.
Source
The information for this article was sourced from ClinicalTrials.gov, a public registry of clinical studies. The trial results were posted on 2026-04-29 for the study titled 'Monitoring Blood Pressure at Home' on clinicaltrials.gov.